Verrica Pharmaceuticals buy Needham & Company LLC
Start price
10.11.23
/
50%
€2.74
Target price
10.11.24
€7.49
Performance (%)
202.37%
Price
17.05.24
€7.94
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Verrica Pharmaceuticals has seen massive gains of 202.37%. This prediction currently runs until 10.11.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | 10.515% | 10.515% |
iShares Core DAX® | -0.383% | 5.021% |
iShares Nasdaq 100 | 1.248% | 4.007% |
iShares Nikkei 225® | 0.525% | -0.109% |
iShares S&P 500 | 0.640% | 3.649% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Needham & Company LLC from $10.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-15.51%
17.05.24
17.05.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
114.49%
17.05.24
17.05.24